Ms. Caroline Michelle Burg, NP Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3601 Houma Blvd Ste 300, Metairie, LA 70006 Phone: 504-412-1240 |
Dr. Thomas Trey Sands, MD Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 3100 Galleria Dr Ste 302, Metairie, LA 70001 Phone: 504-888-4297 Fax: 504-456-2502 |
Hamid Massiha, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3939 Houma Blvd, Suite 216, Metairie, LA 70006 Phone: 504-455-9441 Fax: 504-885-5063 |
Dr. Alireza Sadeghi, MD Plastic Surgery - Plastic Surgery Within the Head and Neck Medicare: May Accept Medicare Assignments Practice Location: 4228 Houma Blvd Ste 100, Metairie, LA 70006 Phone: 504-810-4828 Fax: 504-210-3832 |
Dr. Daniel John Womac, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3440 Division St Ste G, Metairie, LA 70002 Phone: 504-208-4454 |
Dr. John T. Lindsey, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd, Suite 500, Metairie, LA 70006 Phone: 504-885-4508 Fax: 504-885-4715 |
James Bruce Johnson, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4224 Houma Blvd Ste 440, Metairie, LA 70006 Phone: 504-456-5150 Fax: 504-456-5055 |
Edward Matthew Campbell Iv, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4825 Folse Dr, Metairie, LA 70006 Phone: 504-454-6201 |
News Archive
Complementary and alternative medicine may give allergy and asthma sufferers new options for treating symptoms, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16. Allergists discussed how herbal treatments may be integrated into conventional allergy treatments, including a novel Chinese herbal formula for treating all types of food allergies.
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.
Veteran nurses locked out of Alta Bates Summit Medical Center in Oakland said Sunday that the death of a patient due to a medical error by a replacement worker wouldn't have happened if they had been allowed to do their jobs. The hospital's management countered that it was a freak accident that could have happened at any time - with or without the replacement nurses. At the center of the dispute is a cancer patient, a woman who has not been identified but whose tragic death on Saturday has inflamed an already tense labor dispute.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
› Verified 5 days ago